Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
To fulfill the need for global biometrics solutions, CROS NT SRL today announced the acquisition of Stat‐Tech Services, LLC ‐ a Contract Research Organization (CRO) with extensive experience in the medical devices sector. The financial details of the transaction remain confidential.
CROS NT, an international CRO, specializes in biometrics services, and sees the acquisition as an important part of their overall strategy. The deal adds the US to Italy, Germany, and the UK; increasing CROS NT’s geographical reach while adding critical mass to its operation. Stat‐Tech has an excellent reputation for quality and service making it an obvious target for CROS NT, which is seeking to expand while maintaining service excellence.
Paolo Morelli, CEO and President of CROS NT, said, “I am delighted to welcome Stat‐Tech services into the family. The experience and quality of the Stat‐Tech team will add strong value to CROS NT, adding the important area of Medical Devices to our portfolio and allowing us to improve our services to our existing US customers by being closer to them. I was impressed by the reputation of their management and their strong leadership, which we can combine with the existing groups in Europe to field a great team globally.”
“I believe that having highly qualified specialists delivers the best results when conducting clinical trials. CROS NT remains focused on biometrics and by providing expert data services allows its customers to work with clinical CROs appropriate to their therapeutic or geographic needs. We take care of the data collection and the reporting and provide centralized data solutions to maximize the value of those data to the customer,” Paolo added.
George DeMuth, one of the founders of Stat‐Tech Services, LLC and incoming Chief Operating Officer, US Operations, said, “We are very excited about joining CROS NT. This move allows us to provide a broader range of services and additional resources to our existing clients; and provides additional opportunities for growth. CROS NT has a high level of expertise to go with a focus on quality and service; so we knew immediately Stat‐Tech was joining a great team.”
Stat‐Tech Services, LLC is based in Chapel Hill, NC and has been providing biometrics services since 1996. The company has supported numerous approvals in medical devices (501(k)s and PMAs), biologics, and pharmaceutical indications. In addition to data management, study design, and data analysis, Stat‐Tech Services has been involved in numerous FDA interactions including FDA panel meetings.